Intraductal papillary mucinous neoplasm penetrating to the stomach, duodenum, and jejunum demonstrated on MR cholangiopancreatography with an oral negative contrast agent. Issue 1 (12th November 2012)
- Record Type:
- Journal Article
- Title:
- Intraductal papillary mucinous neoplasm penetrating to the stomach, duodenum, and jejunum demonstrated on MR cholangiopancreatography with an oral negative contrast agent. Issue 1 (12th November 2012)
- Main Title:
- Intraductal papillary mucinous neoplasm penetrating to the stomach, duodenum, and jejunum demonstrated on MR cholangiopancreatography with an oral negative contrast agent
- Authors:
- Tajima, Naoshi
Utano, Kenichi
Kijima, Shigeyoshi
Kawai, Akira
Fujita, Akifumi
Sakuma, Kazuya
Sugimoto, Hideharu
Fujii, Hirofumi - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>A 65‐year‐old man was referred to our hospital due to epigastric pain. Abdominal enhanced computed tomography (CT) demonstrated marked dilatation of the main pancreatic duct (MPD) and communication to the gastric and duodenal lumen was suspected. Esophagogastroduodenoscopy (EGD) showed a villous tumor with white mucous discharge in the posterior wall of the gastric corpus and duodenal bulb. Pathological specimens showed mucin‐producing epithelium with nuclear atypia that had developed in a papillary form. Based on these findings, we diagnosed intraductal papillary mucinous neoplasm (IPMN) arising in the MPD with penetration into the gastric and duodenal lumen. Magnetic resonance cholangiopancreatography (MRCP) with an oral negative contrast agent (manganese chloride tetrahydrate) showed a fistulous tract not only to the stomach and duodenum, but also to the jejunum. MRCP demonstrated mucous streaming with remarkably high intensity. In this case, an oral negative contrast agent was useful to distinguish mucous discharge from gastric fluid, facilitating the diagnosis of penetration to the jejunum. This finding was unobtainable by CT or EGD. When IPMN penetrating to other organs is suspected, MRCP with an oral negative contrast agent may provide important information. J. Magn. Reson. Imaging 2013;38:206–209. © 2013 Wiley Periodicals, Inc.</p> </abstract>
- Is Part Of:
- Journal of magnetic resonance imaging. Volume 38:Issue 1(2013)
- Journal:
- Journal of magnetic resonance imaging
- Issue:
- Volume 38:Issue 1(2013)
- Issue Display:
- Volume 38, Issue 1 (2013)
- Year:
- 2013
- Volume:
- 38
- Issue:
- 1
- Issue Sort Value:
- 2013-0038-0001-0000
- Page Start:
- 206
- Page End:
- 209
- Publication Date:
- 2012-11-12
- Subjects:
- Magnetic resonance imaging -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1522-2586 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmri.23915 ↗
- Languages:
- English
- ISSNs:
- 1053-1807
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5010.791000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3755.xml